Author

Niki Stavrou

Observed name: N. Stavrou

Institution: St Savas Hospital

Observed institutions: National and Kapodistrian University of Athens, Alexandra Hospital, St Savas Hospital, Hippocration General Hospital

ORCID: 0000-0001-7578-3001

Observed ORCID: 0000-0001-7578-3001

OpenAlex ID: A5059161429

Development of a Health-Related Quality of Life Tool for Adolescents and Young Adults With Cancer

2025 · Samantha Claire Sodergren, Olga Husson, et al. · JAMA Network Open · 6

Neoadjuvant Imatinib in Recurrent/Metastatic Gastrointestinal Stromal Tumors: A Systematic Review and Meta-analysis of Proportions

2025 · Niki Stavrou, Nikolaos Memos, et al. · Journal of Gastrointestinal Cancer · 2

P-233 Modified FOLFIRINOX as neoadjuvant treatment in patients with borderline resectable and locally advanced pancreatic adenocarcinoma: A single-center study, updated with new data

2023 · S. Ioannou, D. Zouki, et al. · Annals of Oncology · 1

Abstract PS4-08-12: Adherence to Fasting Diet and Mediterranean Diet protocol in women with early stage breast cancer receiving chemotherapy; a randomized clinical trial

2026 · N. Kontou, D. Tryfonopoulos, et al. · Clinical Cancer Research

P-142 Inflammatory biomarkers in patients with advanced pancreatic adenocarcinoma undergoing first-line chemotherapy with nab-paclitaxel and gemcitabine: A single-center study

2022 · A. Ioannou, G. Papaxoinis, et al. · Annals of Oncology

P-145 Modified FOLFIRINOX as neoadjuvant treatment in patients with borderline resectable and locally advanced pancreatic adenocarcinoma: A single-center study

2022 · S. Ioannou, G. Papaxoinis, et al. · Annals of Oncology

Works count: 6

Citation count: 9

H-index: 2

I10-index: